Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$56.16 - $60.96 $10,221 - $11,094
182 Added 1.0%
18,422 $1.12 Million
Q2 2024

Aug 13, 2024

BUY
$53.58 - $57.02 $322,069 - $342,747
6,011 Added 49.15%
18,240 $1.03 Million
Q1 2024

May 10, 2024

BUY
$42.56 - $59.82 $14,044 - $19,740
330 Added 2.77%
12,229 $690,000
Q4 2023

Jan 16, 2024

SELL
$32.18 - $46.57 $4.47 Million - $6.47 Million
-138,862 Reduced 92.11%
11,899 $534,000
Q3 2023

Nov 13, 2023

SELL
$44.2 - $50.2 $1.71 Million - $1.95 Million
-38,787 Reduced 20.46%
150,761 $6.86 Million
Q2 2023

Jul 12, 2023

BUY
$31.86 - $67.26 $2.01 Million - $4.25 Million
63,133 Added 49.94%
189,548 $8.22 Million
Q1 2023

May 02, 2023

BUY
$45.44 - $74.26 $5.71 Million - $9.34 Million
125,770 Added 19499.22%
126,415 $8.31 Million
Q4 2022

Feb 06, 2023

SELL
$41.39 - $81.0 $246,436 - $482,274
-5,954 Reduced 90.23%
645 $29,000
Q3 2022

Oct 18, 2022

BUY
$72.36 - $113.1 $59,262 - $92,628
819 Added 14.17%
6,599 $478,000
Q2 2022

Aug 12, 2022

SELL
$87.2 - $114.05 $295,608 - $386,629
-3,390 Reduced 36.97%
5,780 $620,000
Q1 2022

Apr 05, 2022

BUY
$94.19 - $124.49 $26,090 - $34,483
277 Added 3.11%
9,170 $1.02 Million
Q4 2021

Feb 03, 2022

SELL
$119.57 - $139.07 $584,697 - $680,052
-4,890 Reduced 35.48%
8,893 $1.14 Million
Q3 2021

Oct 15, 2021

SELL
$109.17 - $142.35 $50,327 - $65,623
-461 Reduced 3.24%
13,783 $1.83 Million
Q2 2021

Jul 21, 2021

BUY
$100.34 - $115.69 $497,987 - $574,169
4,963 Added 53.47%
14,244 $1.54 Million
Q1 2021

Apr 05, 2021

SELL
$101.51 - $125.27 $99,581 - $122,889
-981 Reduced 9.56%
9,281 $977,000
Q4 2020

Jan 20, 2021

SELL
$85.88 - $105.36 $552,551 - $677,886
-6,434 Reduced 38.54%
10,262 $1.07 Million
Q3 2020

Oct 19, 2020

BUY
$72.74 - $92.5 $1.21 Million - $1.54 Million
16,696 New
16,696 $1.43 Million
Q2 2020

Jul 29, 2020

SELL
$48.02 - $79.04 $11,236 - $18,495
-234 Closed
0 $0
Q1 2020

Apr 23, 2020

SELL
$36.95 - $62.95 $1.84 Million - $3.13 Million
-49,709 Reduced 99.53%
234 $14,000
Q4 2019

Feb 10, 2020

SELL
$47.06 - $56.64 $179,439 - $215,968
-3,813 Reduced 7.09%
49,943 $2.81 Million
Q3 2019

Oct 10, 2019

SELL
$47.45 - $58.05 $210,061 - $256,987
-4,427 Reduced 7.61%
53,756 $2.56 Million
Q2 2019

Aug 12, 2019

BUY
$39.26 - $54.21 $2.27 Million - $3.14 Million
57,898 Added 20315.09%
58,183 $3.15 Million
Q1 2019

Apr 10, 2019

SELL
$29.84 - $43.92 $10,145 - $14,932
-340 Reduced 54.4%
285 $12,000
Q4 2018

Feb 13, 2019

SELL
$29.95 - $46.34 $1.57 Million - $2.43 Million
-52,352 Reduced 98.82%
625 $19,000
Q3 2018

Nov 14, 2018

BUY
$40.12 - $45.55 $467,718 - $531,021
11,658 Added 28.21%
52,977 $2.41 Million
Q2 2018

Aug 14, 2018

BUY
$38.72 - $42.52 $171,219 - $188,023
4,422 Added 11.98%
41,319 $1.73 Million
Q1 2018

May 14, 2018

BUY
$39.4 - $47.39 $202,831 - $243,963
5,148 Added 16.21%
36,897 $1.52 Million
Q4 2017

Feb 14, 2018

BUY
$37.27 - $43.02 $621,626 - $717,530
16,679 Added 110.68%
31,749 $1.3 Million
Q3 2017

Nov 08, 2017

BUY
$33.75 - $41.67 $508,612 - $627,966
15,070
15,070 $602,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Pacer Advisors, Inc. Portfolio

Follow Pacer Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.